NDLI: Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Pisu, Maria Richman, Joshua Allison, Jeroan J. Williams, O. Dale Kiefe, Catarina I.
Spatial Coverage	United States
Description	Country affiliation: United States Author Affiliation: Pisu M ( Center for Outcomes and Effectiveness Research and Education and Division of Preventive Medicine, Department of Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.)
Abstract	OBJECTIVES: This study examined how physicians perceive pharmaceutical companies' medication assistance programs (MAPs). METHODS: The study was conducted using a survey of 373 primary care physicians from four southern states; they were surveyed within the formative evaluation phase of a larger study (MI-Plus). Respondents were queried about use and usefulness of MAPs for patients who cannot afford drugs, and barriers to using them. Bivariate associations between physician-level variables (patients without drug coverage) and usefulness and barriers to using MAPs were assessed using Chi square tests. Independence of associations was assessed using multiple logistic regressions. RESULTS: Of the 364 (97.6%) respondents who used MAPs, 70% used them regularly, the rest occasionally; 63% found MAPs very useful in caring for patients who could not afford drugs. About 89% reported one or more barriers to using MAPs; 47% saw 'inability of patients to apply directly;' and 57% saw 'enrollment process being time-consuming for staff' as barriers. Compared to physicians with fewer elderly patients without drug coverage, those with more of these patients were less likely to find MAPs very useful; less likely to report no barriers to using MAPs; and more likely to see 'low income thresholds' and 'inability of patients to apply directly' as barriers. CONCLUSION: While MAPs are considered useful in caring for patients in need of assistance, there are many barriers to their use. Pharmaceutical companies should address these barriers. Limitations include a low response rate (about 10%).
File Format	HTM / HTML
ISSN	00384348
e-ISSN	15418243
DOI	10.1097/SMJ.0b013e31818bbe5e
Journal	Southern Medical Journal
Issue Number	2
Volume Number	102
Language	English
Publisher	Lippincott Williams & Wilkins (for the Southern Medical Association)
Publisher Date	2009-02-01
Publisher Place	United States
Access Restriction	Open
Subject Keyword	Discipline Medicine Consumer Behavior Drug Costs Drug Industry Medical Assistance Pharmaceutical Preparations Physicians Chi-square Distribution Logistic Models Medically Uninsured Statistics & Numerical Data Myocardial Infarction Drug Therapy Questionnaires Research Support, N.i.h., Extramural
Content Type	Text
Resource Type	Article
Subject	Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Pharmaceuticals Companies’ Medication Assistance Programs: Potentially Useful but Too Burdensome to Use?

Physician customer satisfaction and medication assistance programs from pharmaceutical companies.

Pharmaceutical companies' medication assistance programs.

Experience with a student-run patient medication assistance service.

The impact of drug samples on prescribing to the uninsured.

Pharmaceutical Manufacturer Assistance Programs

Reducing the burden of medication costs to improve medication adherence.

Companies refuse to deliver drugs as hospital debts soar.

Initial treatment of uninsured patients with ST-elevation myocardial infarction by facility percutaneous coronary intervention capabilities.

Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?

Similar Documents

Pharmaceuticals Companies’ Medication Assistance Programs: Potentially Useful but Too Burdensome to Use?

Physician customer satisfaction and medication assistance programs from pharmaceutical companies.

Pharmaceutical companies' medication assistance programs.

Experience with a student-run patient medication assistance service.

The impact of drug samples on prescribing to the uninsured.

Pharmaceutical Manufacturer Assistance Programs

Reducing the burden of medication costs to improve medication adherence.

Companies refuse to deliver drugs as hospital debts soar.

Initial treatment of uninsured patients with ST-elevation myocardial infarction by facility percutaneous coronary intervention capabilities.

Pharmaceuticals companies' medication assistance programs: potentially useful but too burdensome to use?